Etiology of combined pituitary hormone deficiency: GNAO1 as a novel candidate gene
Status PubMed-not-MEDLINE Jazyk angličtina Země Velká Británie, Anglie Médium electronic-print
Typ dokumentu časopisecké články
PubMed
39078873
PubMed Central
PMC11378134
DOI
10.1530/ec-24-0217
PII: e240217
Knihovny.cz E-zdroje
- Klíčová slova
- combined pituitary hormone deficiency, genetics of short stature, growth hormone deficiency, next-generation sequencing, short stature,
- Publikační typ
- časopisecké články MeSH
Because the causes of combined pituitary hormone deficiency (CPHD) are complex, the etiology of congenital CPHD remains unknown in most cases. The aim of the study was to identify the genetic etiology of CPHD in a well-defined single-center cohort. In total, 34 children (12 girls) with congenital CPHD (growth hormone (GH) deficiency and impaired secretion of at least one other pituitary hormone) treated with GH in our center were enrolled in the study. Their median age was 11.2 years, pre-treatment height was -3.2 s.d., and maximal stimulated GH was 1.4 ug/L. Of them, 30 had central adrenal insufficiency, 27 had central hypothyroidism, ten had hypogonadotropic hypogonadism, and three had central diabetes insipidus. Twenty-six children had a midline defect on MRI. Children with clinical suspicion of a specific genetic disorder underwent genetic examination of the gene(s) of interest via Sanger sequencing or array comparative genomic hybridization. Children without a detected causal variant after the first-tier testing or with no suspicion of a specific genetic disorder were subsequently examined using next-generation sequencing growth panel. Variants were evaluated by the American College of Medical Genetics standards. Genetic etiology was confirmed in 7/34 (21%) children. Chromosomal aberrations were found in one child (14q microdeletion involving the OTX2 gene). The remaining 6 children had causative genetic variants in the GLI2, PROP1, POU1F1, TBX3, PMM2, and GNAO1 genes, respectively. We elucidated the cause of CPHD in a fifth of the patients. Moreover, our study supports the PMM2 gene as a candidate gene for CPHD and suggests pathogenic variants in the GNAO1 gene as a potential novel genetic cause of CPHD.
Zobrazit více v PubMed
Fang Q, George AS, Brinkmeier ML, Mortensen AH, Gergics P, Cheung LYM, Daly AZ, Ajmal A, Pérez Millán MI, Ozel AB, PubMed DOI PMC
Bando H Urai S Kanie K Sasaki Y Yamamoto M Fukuoka H Iguchi G & Camper SA. Novel genes and variants associated with congenital pituitary hormone deficiency in the era of next-generation sequencing. Frontiers in Endocrinology 2022131008306. ( 10.3389/fendo.2022.1008306) PubMed DOI PMC
Hietamaki J Karkinen J Iivonen AP Vaaralahti K Tarkkanen A Almusa H Huopio H Hero M Miettinen PJ & Raivio T. Presentation and diagnosis of childhood-onset combined pituitary hormone deficiency: a single center experience from over 30 years. EClinicalMedicine 202251101556 . ( 10.1016/j.eclinm.2022.101556) PubMed DOI PMC
Budny B Karmelita-Katulska K Stajgis M Żemojtel T Ruchała M & Ziemnicka K. Copy number variants contributing to combined pituitary hormone deficiency. International Journal of Molecular Sciences 2020211–10. ( 10.3390/ijms21165757) PubMed DOI PMC
Hage C Gan HW Ibba A Patti G Dattani M Loche S Maghnie M & Salvatori R. Advances in differential diagnosis and management of growth hormone deficiency in children. Nature Reviews. Endocrinology 202117608–624. ( 10.1038/s41574-021-00539-5) PubMed DOI
Chehadeh-Djebbar El S, Callier P, Masurel-Paulet A, Bensignor C, Méjean N, Payet M, Ragon C, Durand C, Marle N, Mosca-Boidron AL, PubMed DOI
Correa FA, Jorge AAL, Nakaguma M, Canton APM, Costa SS, Funari MF, Lerario AM, Franca MM, Carvalho LR, Krepischi ACV, PubMed DOI
Brisset S, Slamova Z, Dusatkova P, Briand-Suleau A, Milcent K, Metay C, Simandlova M, Sumnik Z, Tosca L, Goossens M, PubMed DOI PMC
Rienzo De F, Mellone S, Bellone S, Babu D, Fusco I, Prodam F, Petri A, Muniswamy R, Luca De F, Salerno M, PubMed DOI
Pérez Millán MI, Vishnopolska SA, Daly AZ, Bustamante JP, Seilicovich A, Bergadá I, Braslavsky D, Keselman AC, Lemons RM, Mortensen AH, PubMed DOI PMC
Obermannova B, Pfaeffle R, Zygmunt-Gorska A, Starzyk J, Verkauskiene R, Smetanina N, Bezlepkina O, Peterkova V, Frisch H, Cinek O, PubMed DOI
Zygmunt-Gorska A Starzyk J Adamek D Radwanska E Sucharski P Herman-Sucharska I & Pietrzyk JJ. Pituitary enlargement in patients with PROP1 gene inactivating mutation represents cystic hyperplasia of the intermediate pituitary lobe. Histopathology and over 10 years follow-up of two patients. Journal of Pediatric Endocrinology & Metabolism 200922653–660. ( 10.1515/jpem.2009.22.7.653) PubMed DOI
Grimberg A DiVall SA Polychronakos C Allen DB Cohen LE Quintos JB Rossi WC Feudtner C & Murad MH. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Hormone Research in Paediatrics 201786361–397. ( 10.1159/000452150) PubMed DOI
Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society 1. Journal of Clinical Endocrinology and Metabolism 2000853990–3993. ( 10.1210/jcem.85.11.6984) PubMed DOI
Persani L Brabant G Dattani M Bonomi M Feldt-Rasmussen U Fliers E Gruters A Maiter D Schoenmakers N & Paul Van Trotsenburg ASP. 2018 European Thyroid Association (ETA) guidelines on the diagnosis and management of central hypothyroidism. European Thyroid Journal 20187225–237. ( 10.1159/000491388) PubMed DOI PMC
Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, PubMed DOI PMC
Gruber LM & Bancos I. Secondary adrenal insufficiency: recent updates and new directions for diagnosis and management. Endocrine Practice 202228110–117. ( 10.1016/j.eprac.2021.09.011) PubMed DOI
Nordenström A, Ahmed SF, Akker van den E, Blair J, Bonomi M, Brachet C, Broersen LHA, Claahsen-van der Grinten HL, Dessens AB, Gawlik A, PubMed DOI PMC
Mishra G & Chandrashekhar SR. Management of diabetes insipidus in children. Indian Journal of Endocrinology and Metabolism 201115(Supplement 3) S180–S187. ( 10.4103/2230-8210.84858) PubMed DOI PMC
Voigt M Fusch C Olbertz D Hartmann K Rochow N Renken C & Schneider K. Analyse des Neugeborenenkollektivs der Bundesrepublik Deutschland. Geburtshilfe und Frauenheilkunde 200666956–970. ( 10.1055/s-2006-924458) DOI
Kobzová J Vignerová J Bláha P Krejćovsky L & Riedlová J. The 6th nationwide anthropological survey of children and adolescents in the Czech Republic in 2001. Central European Journal of Public Health 200412126–130. PubMed
Pruhova S Dusatkova P Sumnik Z Kolouskova S Pedersen O Hansen T Cinek O & Lebl J. Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations. Pediatric Diabetes 201011529–535. ( 10.1111/j.1399-5448.2010.00646.x) PubMed DOI
Plachy L, Strakova V, Elblova L, Obermannova B, Kolouskova S, Snajderova M, Zemkova D, Dusatkova P, Sumnik Z, Lebl J, PubMed DOI
Plachy L, Dusatkova P, Maratova K, Petruzelkova L, Zemkova D, Elblova L, Kucerova P, Toni L, Kolouskova S, Snajderova M, PubMed DOI
Plachy L, Dusatkova P, Maratova K, Petruzelkova L, Elblova L, Kolouskova S, Snajderova M, Obermannova B, Zemkova D, Sumnik Z, PubMed DOI
Plachy L, Amaratunga SA, Dusatkova P, Maratova K, Neuman V, Petruzelkova L, Zemkova D, Obermannova B, Snajderova M, Kolouskova S, PubMed DOI PMC
Fowler A.DECoN: a detection and visualization tool for exonic copy number variants. In: Variant Calling. Methods in Molecular Biology, vol 2493. New York, NY, USA: Humana, 2022. ( 10.1007/978-1-0716-2293-3_6) PubMed DOI
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, PubMed DOI PMC
Jarvik GP & Browning BL. Consideration of cosegregation in the pathogenicity classification of genomic variants. American Journal of Human Genetics 2016981077–1081. ( 10.1016/j.ajhg.2016.04.003) PubMed DOI PMC
Reynaud R Gueydan M Saveanu A Vallette-Kasic S Enjalbert A Brue T & Barlier A. Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. Journal of Clinical Endocrinology and Metabolism 2006913329–3336. ( 10.1210/jc.2005-2173) PubMed DOI
Coya R, Vela A, Perez de Nanclares G, Rica I, Castano L, Busturia MA, Martul P. & GEDPIT group. Panhypopituitarism: genetic versus acquired etiological factors. Journal of Pediatric Endocrinology and Metabolism 20072027–36 . ( 10.1515/JPEM.2007.20.1.27) PubMed DOI
Vieira TC Boldarine VT & Abucham J. Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency. Arquivos Brasileiros de Endocrinologia e Metabologia 2007511097–1103. ( 10.1590/S0004-27302007000700012) PubMed DOI
Navardauskaite R Dusatkova P Obermannova B Pfaeffle RW Blum WF Adukauskiene D Smetanina N Cinek O Verkauskiene R & Lebl J. High prevalence of PROP1 defects in Lithuania: phenotypic findings in an ethnically homogenous cohort of patients with multiple pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism 201499299–306. ( 10.1210/jc.2013-3090) PubMed DOI
Lebl J, Vosáhlo J, Pfaeffle RW, Stobbe H, Černá J, Novotná D, Zapletalová J, Kalvachová B, Hána V, Weiss V, PubMed DOI
Halász Z, Toke J, Patócs A, Bertalan R, Tömböl Z, Sallai A, Hosszú E, Muzsnai A, Kovács L, Sólyom J, PubMed DOI
Plachy L, Petruzelkova L, Dušátková P, Maratova K, Zemkova D, Elblova L, Neuman V, Kolouskova S, Obermannova B, Snajderova M, PubMed DOI PMC
Toni L, Plachy L, Dusatkova P, Amaratunga SA, Elblova L, Sumnik Z, Kolouskova S, Snajderova M, Obermannova B, Pruhova S, PubMed DOI
Hauer NN, Popp B, Schoeller E, Schuhmann S, Heath KE, Hisado-Oliva A, Klinger P, Kraus C, Trautmann U, Zenker M, PubMed DOI PMC
Homma TK, Freire BL, Honjo Kawahira RS, Dauber A, Funari MFA, Lerario AM, Nishi MY, Albuquerque EV, Vasques GA, Collett-Solberg PF, PubMed DOI
Freire BL Homma TK Funari MFA Lerario AM Vasques GA Malaquias AC Arnhold IJP & Jorge AAL. Multigene sequencing analysis of children born small for gestational age with isolated short stature. Journal of Clinical Endocrinology and Metabolism 20191042023–2030. ( 10.1210/jc.2018-01971) PubMed DOI
Miller BS Duffy MM Addo OY & Sarafoglou K. rhIGF-1 therapy for growth failure and IGF-1 deficiency in congenital disorder of glycosylation Ia (PMM2 deficiency). Journal of Investigative Medicine High Impact Case Reports 201312324709613503316. ( 10.1177/2324709613503316) PubMed DOI PMC
Apuzzo D Cappuccio G Vaisanen T Alagia M Pignataro P Genesio R & Brunetti-Pierri N. Two cases of 16q12.1q21 deletions and refinement of the critical region. European Journal of Medical Genetics 202063103878. ( 10.1016/j.ejmg.2020.103878) PubMed DOI
Girisha KM Bidchol AM Graul-Neumann L Gupta A Hehr U Lessel D Nader S Shah H Wickert J & Kutsche K. Phenotype and genotype in patients with Larsen syndrome: clinical homogeneity and allelic heterogeneity in seven patients. BMC Medical Genetics 20161727. ( 10.1186/s12881-016-0290-6) PubMed DOI PMC
Brauner R Bignon-Topalovic J Bashamboo A & McElreavey K. Pituitary stalk interruption syndrome is characterized by genetic heterogeneity. PLoS One 202015e0242358 . ( 10.1371/journal.pone.0242358) PubMed DOI PMC
Čechová A, Honzík T, Edmondson AC, Ficicioglu C, Serrano M, Barone R, Lonlay De P, Schiff M, Witters P, Lam C, PubMed DOI PMC
Saitsu H, Fukai R, Ben-Zeev B, Sakai Y, Mimaki M, Okamoto N, Suzuki Y, Monden Y, Saito H, Tziperman B, PubMed DOI PMC
Hong M & Krauss RS. Cdon mutation and fetal ethanol exposure synergize to produce midline signaling defects and holoprosencephaly spectrum disorders in mice. PLoS Genetics 20128e1002999. ( 10.1371/journal.pgen.1002999) PubMed DOI PMC
Simeone P & Alberti S. Epigenetic heredity of human height. Physiological Reports 20142e12047. ( 10.14814/phy2.12047) PubMed DOI PMC